US20200194771A1 - Medical electrodes having enhanced charge capacities, and methods of manufacturing - Google Patents

Medical electrodes having enhanced charge capacities, and methods of manufacturing Download PDF

Info

Publication number
US20200194771A1
US20200194771A1 US16/712,931 US201916712931A US2020194771A1 US 20200194771 A1 US20200194771 A1 US 20200194771A1 US 201916712931 A US201916712931 A US 201916712931A US 2020194771 A1 US2020194771 A1 US 2020194771A1
Authority
US
United States
Prior art keywords
conductive material
laser
electrodes
electrode
laser process
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US16/712,931
Inventor
Scott Purcell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuxcel Ltd
Original Assignee
Nuxcel Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuxcel Ltd filed Critical Nuxcel Ltd
Priority to US16/712,931 priority Critical patent/US20200194771A1/en
Assigned to NeuroTronik IP Holding (Jersey) Limited reassignment NeuroTronik IP Holding (Jersey) Limited ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: PURCELL, SCOTT
Assigned to NUXCEL LIMITED reassignment NUXCEL LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NeuroTronik IP Holding (Jersey) Limited
Publication of US20200194771A1 publication Critical patent/US20200194771A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01MPROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
    • H01M4/00Electrodes
    • H01M4/02Electrodes composed of, or comprising, active material
    • H01M4/04Processes of manufacture in general
    • H01M4/0402Methods of deposition of the material
    • H01M4/0404Methods of deposition of the material by coating on electrode collectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/0404Electrodes for external use
    • A61N1/0408Use-related aspects
    • A61N1/0456Specially adapted for transcutaneous electrical nerve stimulation [TENS]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0551Spinal or peripheral nerve electrodes
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25DPROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
    • C25D3/00Electroplating: Baths therefor
    • C25D3/02Electroplating: Baths therefor from solutions
    • C25D3/48Electroplating: Baths therefor from solutions of gold
    • H01L51/0037
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E60/00Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
    • Y02E60/10Energy storage using batteries

Definitions

  • the present application generally relates electrodes for delivering energy or stimulus to tissue or structure of the body. More specifically, the application relates to electrode manufacturing processes.
  • delivery of the parasympathetic and sympathetic therapy decreases the patient's heart rate (through the delivery of therapy to the parasympathetic nerves) and elevates or maintains the blood pressure (through the delivery of therapy to the cardiac sympathetic nerves) of the patient in treatment of heart failure.
  • the '699 and '560 applications describe one form of catheter device that may be used to perform transvascular neuromodulation.
  • these applications shows a support or electrode carrying member 10 of the type shown in FIG. 1 on the distal part of a catheter member 4 .
  • the electrode carrying member 10 includes a plurality of struts 12 .
  • One or more of the struts carries one or a plurality of electrodes 17 .
  • the electrode carrying member 10 is designed to bias such electrodes into contact with the vessel wall.
  • the material forming the struts 12 may have a shape set or shape memory that aids in biasing the circumferentially-outward facing surfaces (and thus the electrodes) against the vessel wall.
  • the applications describe that the electrodes 17 may be mounted to or formed onto a substrate 15 that is itself mounted onto a strut or a plurality of strut. It is also disclosed that the struts and electrodes may use flex circuit or printed circuit elements.
  • the rivet is then subjected to a heating process that causes the end of the shank to expand radially and compress longitudinally, forming a secondary head on the opposite end of the shank from the first head.
  • the flexible circuit and strut are thus fixed to one another, captured between the primary head and secondary head of the rivet.
  • Electrodes described in the present application may be used to create an electrode surface, which may on a flex circuit, capable of achieving the current densities needed to carry out the therapy performed in the referenced applications, and for the durations at which therapy could be applied in the acute setting (e.g. up to 96 hours).
  • FIG. 1 shows an electrode carrying member of the type shown in the '699 and '560 applications, with electrodes carried thereon.
  • FIG. 2A shows components of an electrode carrying member prior to assembly, and illustrates a method of assembling the flexible circuit to a strut on the array.
  • FIG. 2B shows the electrode carrying member following assembly with the flexible circuit.
  • FIG. 3A is a flow diagram showing a sequence of steps in a first manufacturing method for enhancing the charge capacity of electrodes.
  • FIG. 3B is a flow diagram showing a sequence of steps in a second manufacturing method for enhancing the charge capacity of electrodes.
  • This application describes processes that may be used to create an electrode surface capable of achieving the current densities needed to carry out the therapy performed in the referenced applications, and for the durations at which therapy could be applied in the acute setting (e.g. up to 96 hours).
  • These processes make use of a laser skiving process or other suitable process to enhance the topography of the electrodes, thus making the electrodes cable of achieving higher charge capacities, and they additionally apply a high specific surface area materials (e.g. IrOx or PEDOT) to the electrode surface to further increase the effective surface area and thus the storage capacity of the electrode surface.
  • a high specific surface area materials e.g. IrOx or PEDOT
  • a flexible circuit is created using flex circuit manufacturing techniques known to those skilled in the art.
  • the flex circuit is plated with thick, electrolytic hard gold plating.
  • a cover layer is applied over the gold electrode surface using an adhesive or adhesiveless process.
  • Step 304 a laser is used to skive the flex circuit. This initial skiving step removes portions of the cover layer to expose electrodes on the flex circuit.
  • the electrodes have an obround geometry, but in other examples electrodes of any shape may be formed.
  • a second laser skiving step is performed in step 308 .
  • a skiving laser is passed over the flex circuit to create increased roughness in the gold electrode material and to remove impurities from the coating surface.
  • the gold electrode surface is coated with a high specific area coating, preferably using electrical deposition. A cyclic voltammetry test may be performed on the electrodes to verify their capability.
  • FIG. 3B A second example of a manufacturing process 400 is shown in FIG. 3B .
  • a flexible circuit is created using flex circuit manufacturing techniques known to those skilled in the art.
  • the flex circuit is plated with thick, electrolytic hard gold plating.
  • Step 402 A laser skiving step is performed in step 404 .
  • a skiving laser is passed over the flex circuit to create increased roughness in the gold electrode material and to remove impurities.
  • the gold electrode surface is coated with a high specific area coating, preferably using electrical deposition. A cyclic voltammetry test may be performed on the electrodes to verify their capability.
  • the processes described above result in creation of a flexible circuit having one or more electrodes, each of which possesses an electrode surface particularly suitable for transvascular stimulation of nerve targets in therapies such as those described in the referenced applications, which require high charge densities over extended time periods (e.g. up to 96 hours).
  • the flexible circuits may be mounted to electrode carrying members such as the strut arrangements described above with respect to FIGS. 1-2B , or alternative electrode carrying members for intravascular or extravascular use.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Electrochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Manufacturing & Machinery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Organic Chemistry (AREA)
  • Electrotherapy Devices (AREA)

Abstract

A method of manufacturing a high charge capacity electrode for delivering electrical energy to target tissue of a patient comprises performing a laser process on a conductive material to increase its surface topography, and then coating the conductive material with a high specific area coating.

Description

  • This application claims the benefit of U.S. Provisional Application No. 62/772,352, filed Dec. 12, 2019.
  • TECHNICAL FIELD OF THE INVENTION
  • The present application generally relates electrodes for delivering energy or stimulus to tissue or structure of the body. More specifically, the application relates to electrode manufacturing processes.
  • BACKGROUND
  • Co-pending U.S. application Ser. No. 13/547,031 entitled System and Method for Acute Neuromodulation, filed Jul. 11, 2012 (Attorney Docket: IAC-1260; the “'031 application”), filed by an entity engaged in research with the owner of the present application, describes a system which may be used for hemodynamic control in the acute hospital care setting, by transvascularly directing therapeutic stimulus to parasympathetic nerves and/or sympathetic cardiac nerves using electrodes positioned in the superior vena cava (SVC). In disclosed embodiments, delivery of the parasympathetic and sympathetic therapy decreases the patient's heart rate (through the delivery of therapy to the parasympathetic nerves) and elevates or maintains the blood pressure (through the delivery of therapy to the cardiac sympathetic nerves) of the patient in treatment of heart failure.
  • Co-pending U.S. application Ser. No. 14/642,699 (the '699), filed Mar. 9, 2015 and U.S. Ser. No. 14/801,560 (the '560), filed Jul. 16, 2015, each incorporated by reference, describe transvascularly directing therapeutic stimulus to parasympathetic and/or sympathetic cardiac nerves using electrodes positioned in the SVC, right brachiocephalic vein, and/or left brachiocephalic vein and/or other sites. As with the system disclosed in the '031, the methods disclosed in these applications can decrease the patient's heart rate (through the delivery of therapy to the parasympathetic nerves) and elevate or maintain the blood pressure (through the delivery of therapy to the cardiac sympathetic nerves) of the patient in treatment of heart failure.
  • The '699 and '560 applications describe one form of catheter device that may be used to perform transvascular neuromodulation. In particular, these applications shows a support or electrode carrying member 10 of the type shown in FIG. 1 on the distal part of a catheter member 4. The electrode carrying member 10 includes a plurality of struts 12. One or more of the struts carries one or a plurality of electrodes 17. The electrode carrying member 10 is designed to bias such electrodes into contact with the vessel wall. The material forming the struts 12 may have a shape set or shape memory that aids in biasing the circumferentially-outward facing surfaces (and thus the electrodes) against the vessel wall. The applications describe that the electrodes 17 may be mounted to or formed onto a substrate 15 that is itself mounted onto a strut or a plurality of strut. It is also disclosed that the struts and electrodes may use flex circuit or printed circuit elements.
  • Co-pending and commonly owned U.S. application Ser. No. ______ (Attorney Ref: NTK2-2010), filed Dec. 12, 2019 and incorporated herein by reference, describes electrode support assemblies in which flexible circuits (having electrodes and/or other components on them) may be mounted to an electrode support. Referring to FIGS. 2A and 2B, the method makes use of a heat staking process to fix a flexible circuit 100 to a strut 102, such as a shape memory strut formed of nitinol or alternative material. The flexible circuit includes the electrodes 103. In general, to carry out the method, the shank of the rivet is passed through a hole 110 in the flexible circuit and an aligned hole 112 in the strut as indicated in FIG. 2A. The rivet is then subjected to a heating process that causes the end of the shank to expand radially and compress longitudinally, forming a secondary head on the opposite end of the shank from the first head. The flexible circuit and strut are thus fixed to one another, captured between the primary head and secondary head of the rivet.
  • Concepts described in the present application may be used to create an electrode surface, which may on a flex circuit, capable of achieving the current densities needed to carry out the therapy performed in the referenced applications, and for the durations at which therapy could be applied in the acute setting (e.g. up to 96 hours).
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 shows an electrode carrying member of the type shown in the '699 and '560 applications, with electrodes carried thereon.
  • FIG. 2A shows components of an electrode carrying member prior to assembly, and illustrates a method of assembling the flexible circuit to a strut on the array. FIG. 2B shows the electrode carrying member following assembly with the flexible circuit.
  • FIG. 3A is a flow diagram showing a sequence of steps in a first manufacturing method for enhancing the charge capacity of electrodes.
  • FIG. 3B is a flow diagram showing a sequence of steps in a second manufacturing method for enhancing the charge capacity of electrodes.
  • DETAILED DESCRIPTION
  • This application describes processes that may be used to create an electrode surface capable of achieving the current densities needed to carry out the therapy performed in the referenced applications, and for the durations at which therapy could be applied in the acute setting (e.g. up to 96 hours). These processes make use of a laser skiving process or other suitable process to enhance the topography of the electrodes, thus making the electrodes cable of achieving higher charge capacities, and they additionally apply a high specific surface area materials (e.g. IrOx or PEDOT) to the electrode surface to further increase the effective surface area and thus the storage capacity of the electrode surface.
  • In accordance with a first example of an electrode manufacturing method 300 illustrated in FIG. 3A, a flexible circuit is created using flex circuit manufacturing techniques known to those skilled in the art. The flex circuit is plated with thick, electrolytic hard gold plating. Step 302. A cover layer is applied over the gold electrode surface using an adhesive or adhesiveless process. Step 304. In step 306, a laser is used to skive the flex circuit. This initial skiving step removes portions of the cover layer to expose electrodes on the flex circuit. In preferred examples, the electrodes have an obround geometry, but in other examples electrodes of any shape may be formed. A second laser skiving step is performed in step 308. In this second skiving step, a skiving laser is passed over the flex circuit to create increased roughness in the gold electrode material and to remove impurities from the coating surface. Finally, in step 310, the gold electrode surface is coated with a high specific area coating, preferably using electrical deposition. A cyclic voltammetry test may be performed on the electrodes to verify their capability.
  • A second example of a manufacturing process 400 is shown in FIG. 3B. In this embodiment, a flexible circuit is created using flex circuit manufacturing techniques known to those skilled in the art. The flex circuit is plated with thick, electrolytic hard gold plating. Step 402. A laser skiving step is performed in step 404. In this skiving step, a skiving laser is passed over the flex circuit to create increased roughness in the gold electrode material and to remove impurities. Finally, in step 406, the gold electrode surface is coated with a high specific area coating, preferably using electrical deposition. A cyclic voltammetry test may be performed on the electrodes to verify their capability.
  • The processes described above result in creation of a flexible circuit having one or more electrodes, each of which possesses an electrode surface particularly suitable for transvascular stimulation of nerve targets in therapies such as those described in the referenced applications, which require high charge densities over extended time periods (e.g. up to 96 hours). The flexible circuits may be mounted to electrode carrying members such as the strut arrangements described above with respect to FIGS. 1-2B, or alternative electrode carrying members for intravascular or extravascular use.
  • All applications and patents referred to herein, including for purposes of priority, and incorporated herein by reference.

Claims (13)

What is claimed is:
1. A method of manufacturing an electrode for use in delivering electrical energy to target tissue of a patient, the method comprising:
providing a conductive material;
performing a laser process on the conductive material to increase its surface topography; and
coating the conductive material with a high specific area coating.
2. The method according to claim 1, wherein the method includes providing a flexible circuit having the conductive material thereon.
3. The method according to claim 1, wherein the conductive material is electrolytic hard gold plating on a flexible circuit.
4. The method of claim 1, wherein the high specific area coating is IrOx.
5. The method of claim 1, wherein the high specific area coating is PEDOT.
6. The method of claim 1, further including the step of, before performing the laser process, applying a cover layer over the conductive material.
7. The method of claim 6, wherein the cover layer is applied using an adhesiveless process.
8. The method of claim 6, wherein the cover layer is applied using an adhesive process.
9. The method of claim 6, wherein the laser process is a second laser process, and wherein the method further includes the step of performing an initial laser skiving step to remove a portion of the cover layer, to expose an electrode of a desired shape and size.
10. The method of claim 9, wherein the second laser process additional removes impurities from the coating.
11. The method of claim 1, wherein the laser process is a laser skiving process.
12. The method of claim 2, further including the step of mounting the flexible circuit to an electrode carrying member proportioned for positioning in venous vasculature superior to the heart of a human adult for delivery, using the electrodes, of the electrical energy to nerve targets outside the brachiocephalic vein.
13. The method of claim 12, wherein the electrode carrying member is proportioned for positioning in brachiocephalic vein of a human adult to permit placement of the electrodes in contact with a posterior surface of said brachiocephalic vein.
US16/712,931 2018-12-12 2019-12-12 Medical electrodes having enhanced charge capacities, and methods of manufacturing Abandoned US20200194771A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US16/712,931 US20200194771A1 (en) 2018-12-12 2019-12-12 Medical electrodes having enhanced charge capacities, and methods of manufacturing

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862778352P 2018-12-12 2018-12-12
US16/712,931 US20200194771A1 (en) 2018-12-12 2019-12-12 Medical electrodes having enhanced charge capacities, and methods of manufacturing

Publications (1)

Publication Number Publication Date
US20200194771A1 true US20200194771A1 (en) 2020-06-18

Family

ID=71073755

Family Applications (1)

Application Number Title Priority Date Filing Date
US16/712,931 Abandoned US20200194771A1 (en) 2018-12-12 2019-12-12 Medical electrodes having enhanced charge capacities, and methods of manufacturing

Country Status (1)

Country Link
US (1) US20200194771A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10952665B2 (en) 2016-03-09 2021-03-23 CARDIONOMIC, Inc. Methods of positioning neurostimulation devices
US11077298B2 (en) 2018-08-13 2021-08-03 CARDIONOMIC, Inc. Partially woven expandable members
US11559687B2 (en) 2017-09-13 2023-01-24 CARDIONOMIC, Inc. Methods for detecting catheter movement
US11607176B2 (en) 2019-05-06 2023-03-21 CARDIONOMIC, Inc. Systems and methods for denoising physiological signals during electrical neuromodulation
US11986650B2 (en) 2006-12-06 2024-05-21 The Cleveland Clinic Foundation Methods and systems for treating acute heart failure by neuromodulation

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130090542A1 (en) * 2010-06-18 2013-04-11 The Regents Of The University Of Michigan Implantable micro-component electrodes
US20130282092A1 (en) * 2003-05-01 2013-10-24 Second Sight Medical Products, Inc. Adherent Metal Oxide Coating Forming a High Surface Area Electrode
US20140357973A1 (en) * 2013-05-30 2014-12-04 Pulse Technologies, Inc. Biocompatible implantable electrode
US20160174860A1 (en) * 2013-08-15 2016-06-23 Advanced Bionics Ag Surface modified electrodes
US20180008821A1 (en) * 2016-07-05 2018-01-11 Pacesetter, Inc. Implantable thin film devices

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130282092A1 (en) * 2003-05-01 2013-10-24 Second Sight Medical Products, Inc. Adherent Metal Oxide Coating Forming a High Surface Area Electrode
US20130090542A1 (en) * 2010-06-18 2013-04-11 The Regents Of The University Of Michigan Implantable micro-component electrodes
US20140357973A1 (en) * 2013-05-30 2014-12-04 Pulse Technologies, Inc. Biocompatible implantable electrode
US20160174860A1 (en) * 2013-08-15 2016-06-23 Advanced Bionics Ag Surface modified electrodes
US20180008821A1 (en) * 2016-07-05 2018-01-11 Pacesetter, Inc. Implantable thin film devices

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11986650B2 (en) 2006-12-06 2024-05-21 The Cleveland Clinic Foundation Methods and systems for treating acute heart failure by neuromodulation
US10952665B2 (en) 2016-03-09 2021-03-23 CARDIONOMIC, Inc. Methods of positioning neurostimulation devices
US11229398B2 (en) 2016-03-09 2022-01-25 CARDIONOMIC, Inc. Electrode assemblies for neurostimulation treatment
US11806159B2 (en) 2016-03-09 2023-11-07 CARDIONOMIC, Inc. Differential on and off durations for neurostimulation devices and methods
US11559687B2 (en) 2017-09-13 2023-01-24 CARDIONOMIC, Inc. Methods for detecting catheter movement
US11077298B2 (en) 2018-08-13 2021-08-03 CARDIONOMIC, Inc. Partially woven expandable members
US11648395B2 (en) 2018-08-13 2023-05-16 CARDIONOMIC, Inc. Electrode assemblies for neuromodulation
US11607176B2 (en) 2019-05-06 2023-03-21 CARDIONOMIC, Inc. Systems and methods for denoising physiological signals during electrical neuromodulation

Similar Documents

Publication Publication Date Title
US20200194771A1 (en) Medical electrodes having enhanced charge capacities, and methods of manufacturing
US7925352B2 (en) System and method for transvascularly stimulating contents of the carotid sheath
US8229564B2 (en) Neuromodulatory methods for treating pulmonary disorders
US20140316496A1 (en) Intravascular Electrode Arrays for Neuromodulation
Kane et al. Electrical performance of penetrating microelectrodes chronically implanted in cat cortex
RU2452529C2 (en) Method for making neurostimulation chain and neurostimulation chain
US7974707B2 (en) Electrode assembly with fibers for a medical device
US10271752B2 (en) Detection/stimulation microlead implantable in a vessel of the venous, arterial or lymphatic network
US7603178B2 (en) Electrical stimulation lead, system, and method
EP2061550B1 (en) Multi-electrode assembly for an implantable medical device
KR101450859B1 (en) Nerve electrode provided with a antiinflammatory drug and method for manufacturing the same
JP6639406B2 (en) Systems and methods for neuromodulation therapy of the sympathetic and parasympathetic cardiac nerves
JPH06312025A (en) Human body stimulating/sensing lead, its electrode, and manufacture of said electrode
US11395921B2 (en) Intravascular electrode arrays for neuromodulation
US11752330B2 (en) Electrode body of an electrode assembly and electrode assembly for electrical stimulation, and method for producing an electrode assembly
US20090204194A1 (en) Medical system including a novel bipolar pacing pair
US7191016B2 (en) Medical system including a novel bipolar pacing and sensing pair
Noda et al. Performance improvement and functionalization of an electrode array for retinal prosthesis by iridium oxide coating and introduction of smart-wiring technology using CMOS microchips
Jung et al. Bionic intrafascicular interfaces for recording and stimulating peripheral nerve fibers
US8676343B2 (en) Multi-electrode leads for brain implantation
JP2018514265A (en) System and method for generating a therapeutic electric field for capturing a target of a neural system
US7459369B2 (en) High capacitance low resistance electrode
US11833356B2 (en) Extraneural cuff with flexible interconnects for stimulation and recording
Lee et al. Flexible sling electrode for bidirectional neural signal recording and selective stimulation
US20210252251A1 (en) Methods and systems for treatment of insomnia using deep brain stimulation

Legal Events

Date Code Title Description
STPP Information on status: patent application and granting procedure in general

Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED

AS Assignment

Owner name: NEUROTRONIK IP HOLDING (JERSEY) LIMITED, JERSEY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PURCELL, SCOTT;REEL/FRAME:052616/0001

Effective date: 20200430

AS Assignment

Owner name: NUXCEL LIMITED, IRELAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NEUROTRONIK IP HOLDING (JERSEY) LIMITED;REEL/FRAME:052794/0013

Effective date: 20200512

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO PAY ISSUE FEE